Rx · Prescription onlyInjected under the skin
Tirzepatide + Glycine
Medical weight management.
Your plan
$150/mo, $899 billed once for 6 months/mo
$899 billed once for 6 months · unused months refunded on a medical stop
No membership fee · this is the full price · free shipping · avg 4-week supply
- Medication, clinician care and dose adjustments, all in one price.
- ~28-day supply. Your clinician sets your exact dose, so yours may vary; your refill arrives as you finish the last one.
A licensed clinician on our care team reviews every request and prescribes only when it's clinically appropriate.
FDA status: Compounded medication, not FDA-approved. Its active ingredient, tirzepatide, is also in the FDA-approved drugs Mounjaro and Zepbound; this compounded version is not one of them.
About
Tirzepatide + Glycine.
A clinician-guided tirzepatide plan designed to support appetite regulation, metabolic health, and long-term care beyond the scale, with glycine for tolerance.
What it's for
- Weight loss
- Appetite regulation
- Metabolic health
- Tolerance
Supply per fill
28-day
About 4 weeks per vial at your prescribed dose; your clinician confirms the exact dose.
Clinician review
Under 1 hr
Most cases are reviewed by a licensed clinician in under an hour.
Pharmacy
US-licensed
Compounded to your prescription at a US-licensed pharmacy and shipped to your door.
Shipping, always
Free
Every order ships free and cold: medication, clinician care and refills, one price.
Tirzepatide + Glycine vs. Zepbound
Zepbound (brand name)
$1,086
per 28-day supply at list price
Zepym Tirzepatide + Glycine
from $150/mo
About 86% less than the brand's list price
Zepbound list price (wholesale acquisition cost) as published by Eli Lilly, $1,086.37 per 28-day supply, checked November 11, 2026. Lilly also sells Zepbound vials to self-pay patients for $299 to $449 a month, depending on the dose. Compounded medication, not FDA-approved, and not the brand-name drug. Eli Lilly
Formulation
Injectable vial2 mL
- Tirzepatidecompounded to your dose
- Glycineincluded
Your protocol
How it's prescribed.
Who it's for
- Adults with a BMI of 30 or more
- Adults with a BMI of 25 to 29.9 and a weight-related condition, case by case
- People who want tirzepatide's stronger effect and want to protect muscle while losing fast.
- People who want a clinician to set their dose and adjust it at check-ins
Your clinician decides whether Tirzepatide + Glycine is right for you after reviewing your health history.
Directions & duration
Inject 50 units (0.5 mL) under the skin once a week.
Cycle. Weekly injection; one vial lasts 4 weeks. At your first visit your clinician sets your starting dose and the steps up for the months ahead; each refill ships at the next step, and your clinician can hold or change it.
One price. The price is the same at every dose, so a higher dose never costs more.
Directions shown are the pharmacy's for this preparation. Your prescription label is the final word.
What's included
- Personalized, clinician-guided plan
- Monthly, 3-month and 6-month plans
- Same price at every dose, no dose upcharges
- Dispensed by a US-licensed compounding pharmacy
- Unlimited dose adjustments and messaging
- Ongoing support and check-ins
- Pause or cancel anytime
- Sterile syringes and alcohol prep pads
- Free shipping, kept cold
Storage & handling
- Keep refrigerated at 36–46 °F (2–8 °C) at all times, including before first use.
- One vial is a 4-week supply: use it within 4 weeks and discard what is left, as the label says.
- Protect from light. Wipe the stopper with an alcohol pad before every draw.
- Use each syringe once and dispose of it in a sharps container.
A typical course.
- Day 1
- A US-licensed clinician reviews your health profile, goals and treatment history and sets your starting dose.
- 7 Days
- Your first weekly injection. Appetite usually quiets within days; some nausea in the first weeks is common and fades as the dose settles.
- 30 Days
- Fullness comes sooner and cravings soften. Your clinician checks how you feel before any dose increase.
2 more stages
- 6 Months
- Weight loss builds steadily with the plan, food and movement. Doses are adjusted at your check-ins.
- 1 Year and Beyond
- Maintenance is part of the plan: your clinician decides with you how to hold your results or taper.
Individual results vary. A licensed clinician decides whether treatment is appropriate and follows your progress.
The science
How it works, and what the research shows.
How it works
Your body makes GLP-1 and GIP after you eat.
They are the signals that tell the brain “we've had enough,” slow digestion and steady blood sugar.
Tirzepatide mimics both hormones at once, which is why it produced the largest weight loss seen in clinical trials of this class.
Clinical evidence
Weight: about 21%
SURMOUNT-1: 2,539 adults with obesity, or overweight with a weight-related condition, 72 weeks of weekly injections at 5, 10 or 15 mg. At 15 mg the mean loss was 20.9% (intention to treat), against 3.1% on placebo.
SURMOUNT-1, NEJM 2022
2 more findings
Head to head: 20.2% vs 13.7%
SURMOUNT-5: 751 adults without diabetes, open label, 72 weeks. Maximum tolerated tirzepatide (10 or 15 mg) lost 20.2% on average; maximum tolerated semaglutide (1.7 or 2.4 mg) lost 13.7%.
SURMOUNT-5, NEJM 2025Large losses: 57% lost 20% or more
SURMOUNT-1 at 15 mg: 57% of people reached a loss of at least 20% of body weight, against 3% on placebo. The average hides a wide spread between people.
SURMOUNT-1, NEJM 2022
Full references with links are listed further down the page.
- 5ReferencesPeer-reviewed studies, each with its link
- 7Sectionsweight, against semaglutide, sleep apnea
- 6min readUpdated Oct 9, 2026
References
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022. · NEJM
- Aronne LJ et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med 2025. · NEJM
- Tirzepatide for the treatment of obstructive sleep apnea and obesity (SURMOUNT-OSA). N Engl J Med 2024. · NEJM
- Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity (SURMOUNT-4). JAMA 2024. · JAMA
- Zepbound (tirzepatide) injection, prescribing information, dosage and administration. · DailyMed
Before you start
Important safety information
FDA status: Compounded medication, not FDA-approved. Its active ingredient, tirzepatide, is also in the FDA-approved drugs Mounjaro and Zepbound; this compounded version is not one of them.
Boxed warning
GLP-1 medications carry a boxed warning about thyroid C-cell tumors seen in rodents: do not use if you or a family member has had medullary thyroid carcinoma or MEN 2.
Side effects and precautions
- Tirzepatide can cause nausea, vomiting, diarrhea, constipation, stomach pain, reduced appetite, fatigue and injection-site reactions, most often in the first weeks and when the dose goes up.
Get care right away
- Stop and seek care for severe stomach pain (possible pancreatitis or gallbladder problems), signs of an allergic reaction, or vision changes if you have diabetes.
When it isn't prescribed
- Not for use in pregnancy or breastfeeding, or with a history of pancreatitis.
Tell your clinician about diabetes medication, insulin and every medication you take.
How supplied
Every strength: 50 units (0.5 mL) a week
| Dose | Vial | Concentration | Each week |
|---|---|---|---|
| 2.5 mg | 10 mg / 2 mL | 5 mg/mL | 50 units (0.5 mL) |
| 5 mg | 20 mg / 2 mL | 10 mg/mL | 50 units (0.5 mL) |
| 7.5 mg | 30 mg / 2 mL | 15 mg/mL | 50 units (0.5 mL) |
| 10 mg | 40 mg / 2 mL | 20 mg/mL | 50 units (0.5 mL) |
| 12.5 mg | 50 mg / 2 mL | 25 mg/mL | 50 units (0.5 mL) |
| 15 mg | 60 mg / 2 mL | 30 mg/mL | 50 units (0.5 mL) |
Frequently asked.
How is compounded tirzepatide different from Mounjaro and Zepbound?
Mounjaro and Zepbound are brand-name, FDA-approved products made by Eli Lilly. Our tirzepatide is compounded for you by a US-licensed pharmacy and is not FDA-approved; the FDA does not review compounded drugs for safety, effectiveness or quality. A licensed clinician decides whether it is right for you.
How much does Tirzepatide + Glycine cost?
1 month: $259/mo; 3 months: $166/mo ($499 billed once); 6 months: $150/mo ($899 billed once). The price is the same at every dose, shipping is free and there is no membership fee.
Do I need a prescription for Tirzepatide + Glycine?
Yes. It is prescription-only: a licensed clinician on our care team reviews your health history and prescribes only when it's clinically appropriate.
How do I take Tirzepatide + Glycine?
Inject 50 units (0.5 mL) under the skin once a week; one vial lasts 4 weeks. Your clinician sets your dose, and your prescription label is the final word.
How does tirzepatide help with weight loss?
It mimics two gut hormones at once, GLP-1 and GIP, that tell your brain you're full, slow how fast your stomach empties and steady blood sugar after meals. You feel satisfied with less food, so eating less becomes sustainable rather than a fight.
What does the glycine add?
Glycine is an amino acid that supports steadier digestion and sleep. Many members tolerate the first weeks better with it.
What are the side effects?
Nausea, constipation, diarrhea and fatigue are the most common, usually in the first weeks and after a dose increase, and they fade as your body adjusts. Serious but rare risks include pancreatitis and gallbladder problems; read the safety information above and tell your clinician about any history of pancreatitis or thyroid cancer.
What happens when I reach my goal?
Your clinician decides with you: some people hold a maintenance dose, others taper down gradually. Either way, the plan includes the habits, food and movement that keep the weight off.
More options in this area.
Semaglutide + Glycine
Medical weight management
From $99 · 4-week supply
6 strengths · 250 mcg – 2.5 mg
Ready to start with Tirzepatide + Glycine?
Licensed clinicians. One price at every dose. Free shipping, kept cold.
$150/mo · $899 billed once for 6 months
- Free shipping
- No membership fee
- Same price at every dose
- HSA and FSA accepted
